← Eichor
Study identifier: NCT04159818 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Immune Induction Strategies to Improve Response to Immune Checkpoint Blockade in Triple Negative Breast Cancer (TNBC) Patients

Condition: Metastatic Breast Cancer  ·  Sponsor: The Netherlands Cancer Institute

PhasePhase 2
Planned participants52
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

This is a single center non-blinded randomized multi-cohort non-comparative phase II trial with a Simon's two-stage design.

This description comes directly from the study's public registry record.

Talk to the study team

Marleen Kok, MD  ·  +3120 512  ·  m.kok@nki.nl

Leonie Voorwerk, MD  ·  +3120 512  ·  l.voorwerk@nki.nl

Always discuss trial participation with your own doctor first.

Locations (1)

Antoni van LeeuwenhoekAmsterdam, NetherlandsRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT04159818